RAD 402 is a humanized IgG1 internalized by prostate cells, binding KLK3 with high affinityTb-161 antitumor activity driven by the dual emission ...

A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and ...

It’s not the kind of news anyone wants to hear,” the actor said in a recent interview with Black Health Matters.

The EMA’s assessment confirms the treatment matches the reference drug in quality and performance, potentially expanding ...

Osaka, Japan - A research team at Osaka University will start an investigator-initiated clinical trial for refractory prostate cancer patients after successful development of a new alpha-ray ...

The deal gives J&J access to a pipeline of drugs designed to “hold and kill” tumors, led by a prostate cancer medicine that’s ...

This collaboration supports the advancement of the EpiCapture test, which is currently in late-stage development, to regulatory approval and commercialization. This initiative is part of Trinity ...

Treating prostate cancer with immunotherapy is currently difficult to do. But results from a first in-human phase 1 trial using a chimeric antigen receptor (CAR) T cell therapy developed by ...

Figure 1: a, Detection of pp32-related mRNA in benign prostate tissue and prostate cancer. Figure 2: a, Amplification of pp32 and pp32 variants from human prostate cancer. Multiple pairwise alignment ...

Grey's Anatomy star James Pickens Jr, known for his longtime association with the medical drama series, has revealed his ...

In the season 22 midseason finale of the medical drama, it was revealed that Pickens' character, Dr. Richard Webber, has ...